Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant

Journal of Virological Methods

Volumn 185, Issue 1, 2012, Pages 124-128

  Cao, Yimei ^a   Lu, Zengjun ^a   Li, Pinghua ^a   Sun, Pu ^a   Fu, Yuanfang ^a   Bai, Xingwen ^a   Bao, Huifang ^a   Chen, Yingli ^a   Li, Dong ^a   Liu, Zaixin ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Adjuvant; Foot and mouth disease virus (FMDV); Multi epitope peptide; Poly (I:C)

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; MULTI EPITOPE PEPTIDE VACCINE; NEUTRALIZING ANTIBODY; PEPTIDE VACCINE; POLYINOSINIC POLYCYTIDYLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HUMORAL IMMUNITY; IMMUNOGENICITY; INFECTION CONTROL; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEROTYPE; VACCINE PRODUCTION; VIRUS NEUTRALIZATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; EPITOPES; FEMALE; FOOT-AND-MOUTH DISEASE VIRUS; MICE; MICE, INBRED BALB C; POLY I-C; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; MUS;

EID: 84864301188     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.03.036     Document Type: Article

References (33)

1. Agadjanyan M.G., Ghochikyan A., Petrushina I., Vasilevko V., Movsesyan N., Mkrtichyan M., Saing T., Cribbs D.H. Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from β-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide. The Journal of Immunology 2005, 174:1580-1586.
2. Aggarwal N., Barnett P.V. Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species. Journal of General Virology 2002, 83:775-782.
3. Bai X.W., Li P.H., Bao H.F., Liu Z.X., Li D., Lu Z.J., Cao Y.M., Shang Y.J., Shao J.J., Chang H.Y., Luo J.X., Liu X.T. Evolution and molecular epidemiology of foot-and-mouth disease virus in China. Chinese Science Bulletin 2011, 56:2191-2201.
4. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., Rowlands D.J., Brown F. Protection against foot-and-mouth disease by immunisation with a chemically synthesised peptide predicted from the viral nucleotide sequence. Nature 1982, 298:30-33.
5. Cao Y.M., Lu Z.J., Sun J.C., Bai X.W., Sun P., Bao H.F., Chen Y.L., Guo J.H., Liu X.T., Liu Z.X. Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs. Veterinary Microbiology 2009, 137:10-17.
6. Cooke J.N., Westover K.M. Serotype-specific differences in antigenic regions of foot-and-mouth disease virus (FMDV): a comprehensive statistical analysis. Infection. Genetics and Evolution 2008, 8:855-863.
7. Cunliffe H.R., Richmond J.Y., Campbell C.H. Interferon inducers and foot-and-mouth disease vaccines: influence of two synthetic polynucleotides on antibody response and immunity in guinea pigs and swine. Canadian Journal of Comparative Medicine 1977, 41:117-121.
8. Derbyshire J.B., Lesnick C.E. The effect of interferon induction in newborn piglets on the humoral immune response to oral vaccination with transmissible gastroenteritis virus. Veterinary Immunology and Immunopathology 1990, 24:227-234.
9. Doel T.R. Optimization of the immune response to foot-and-mouth disease vaccines. Vaccine 1999, 17:1761-1771.
10. Donaldson A.I., Alexandersen S., Sørensen J.H., Mikkelsen T. Relative risks of the uncontrollable (airborne) spread of FMD by different species. Veterinary Record 2001, 148:602-604.
11. Du Y.J., Li Y.F., He H.R., Qi J., Jiang W.M., Wang X.L., Tang B., Cao J., Wang X.W., Jiang P. Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon in mice and protective efficacy in guinea pigs and swine. Journal of Virological Methods 2008, 149:144-152.
12. Dunn C.S., Donaldson A.I. Natural adaption to swine of a Taiwanese isolate of foot-and-mouth disease virus. Veterinary Record 1997, 141:174-175.
13. Francis M.J., Hastings G.Z., Brown F., Mcdermed J., Lu Y.A., Tam J.P. Immunological evaluation of the multiple antigen peptide (Map) system using the major immunogenic site of foot-and-mouth-disease virus. Immunology 1991, 73:249-254.
14. Francis M.J., Hastings G.Z., Clarke B.E., Brown A.L., Beddell C.R., Rowlands D.J., Brown F. Neutralising antibodies to all seven serotypes of foot-and mouth disease virus elicited by synthetic peptides. Immunology 1990, 69:171-176.
15. Houston W.E., Crabbs C.L., Stephen E.L., Levy H.B. Modified polyriboinosinic-polyribocytidylic acid, an immunological adjuvant. Infection and Immunity 1976, 14:318-319.
16. Knight D.J., Leiper J.W., Gough R.E., Allan W.H. Continued studies on the adjuvancy effect of natural and synthetic double-stranded RNA preparations with inactivated Newcastle disease vaccines in fowls. Research in Veterinary Science 1977, 23:38-42.
17. Le Bon A., Schiavoni G.D., Agostino G., Gresser I., Belardelli F., Tough D.F. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001, 14:461-470.
18. Le Bon A., Thompson C., Kamphuis E., Durand V., Rossmann C., Kalinke U., Tough D.F. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. Journal of Immunology 2006, 176:2074-2078.
19. Longhi M.P., Trumpfheller C., Idoyaga J., Caskey M., Matos I., Kluger C., Salazar A.M., Colonna M., Steinman R.M. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. Journal of Experimental Medicine 2009, 206:1589-1602.
20. Maes R.F., Vieira A., Gomes I., Auge de Mello P., Bernal Lopez C., Costa Freitas K. Potentiation of FMD vaccines with polycationic-nucleic acid complexes. Archives of Virology 1977, 55:275-285.
21. Mateu M.G., Da Silva J.L., Rocha E., De Brum D.L., Alonso A., Enjuanes L., Domingo E., Barahona H. Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. Virology 1988, 167:113-124.
22. Mateu M.G., Hernandez J., Martinez M.A., Feigelstock D., Lea S., Perez J.J., Giralt E., Stuart D., Palma E.L., Domingo E. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. Journal of Virology 1994, 68:1407-1417.
23. Meloen R.H., Casal J.I., Dalsgaard K., Langeveld J.P.M. Synthetic peptide vaccines: success at last. Vaccine 1995, 13:885-886.
24. Meylan E., Tschopp J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Molecular Cell 2006, 22:561-569.
25. Morgan D.O., Moore D.M. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. American Journal of Veterinary Research 1990, 51:40-45.
26. Pfaff E., Mussgay M., Bohm H.O., Schulz G.E., Schaller H. Antibodies against a preselected peptide recognise and neutralise foot and mouth disease virus. EMBO Journal 1982, 1:869-874.
27. Rappuoli R., Mandl C.W., Black S., De Gregorio E. Vaccines for the twenty-first century society. Nature Reviews Immunology 2011, 11:865-872.
28. Shao J.J., Wong C.K., Lin T., Lee S.K., Cong G.Z., Sin F.W.Y., Du J.Z., Gao S.D., Liu X.T., Cai X.P., Xie Y., Chang H.Y., Liu J.X. Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type O in swine. Clinical and Vaccine Immunology 2011, 18:143-149.
29. Strohmaier K., Franze R., Adam K.H. Location and characterization of the antigenic portion of the FMDV immunising protein. Journal of General Virology 1982, 59:295-306.
30. Taboga O., Tami C., Carrillo E., Núñez J.I., Rodríguez A., Saíz J.C., Blanco E., Valero M.L., Roig X., Camarero J.A., Andreu D., Mateu M.G., Giralt E., Domingo E., Sobrino F., Palma E.L. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. Journal of Virology 1997, 71:2606-2614.
31. Wang C.Y., Chang T.Y., Walfield A.M., Ye J., Shen M., Chen S.P., Li M.C., Lin Y.L., Jong M.H., Yang P.C., Chyr N., Kramer E., Brown F. Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 2002, 20:2603-2610.
32. Zamorano P., Wigdorovitz A., Perez-Filgueira M., Carrillo C., Escribano J.M., Sadir A.M., Borca M.V. A 10-amino-acid linear sequence of VP1 of foot-and-mouth disease virus containing B- and T-cell epitopes induces protection in mice. Virology 1995, 212:614-621.
33. Zheng H., He J., Guo J., Jin Y., Yang F., Lv L., Liu X. Genetic characterization of a new pandemic Southeast Asia topotype strain of serotype O foot-and-mouth disease virus isolated in China during 2010. Virus Genes 2011, (September):20. 10.1007/s11262-011-0670-0.